The Northwest Region Hospitals Epic Transition team will be hosting a Provider Roadshow on October 29, 8:00am – 2:00pm. The purpose of this roadshow is to allow providers the opportunity to stop by, ask questions, see Epic functionality and workflows, and get more information about the upcoming transition to Epic and how it will impact you.
Representatives from Training, Epic Project Leadership, Provider Leadership, as well as team members from various Epic applications will be there to provide demonstrations and answer your questions. Note, this is not a training event. However, you can get information about training enrollment, training tracks, training hours, etc.
Please plan to take a few minutes to come by the medical staff lounge and get informed!
Nursing and pharmacy will list patient allergies in the EMR. The severity of the allergy cannot be assessed by the nursing and pharmacy staff. Therefore the allergy severity will be listed as “unknown”. This will default to the presumed to be severe for the drug alerting.
Physicians can go and edit the severity based on history and clinical judgement.
Please edit the informant source to physician. This will allow the severity to flow from one admission to the next.
Paragon 14 went live at 6pm Sunday March 18, 2018.
Current known issues:
Census issues – Some EMPG hospitalists did have issues with missing patients from default census. Solution: Please review your filters, please look at “Groups”. Make sure “Hospitalist Physicians Med Grp of Ill LLC” is checked. Please save the filter. – resolved 03/22/18 10am
E-prescription error – This issue has been resolved. If you were able to send electronic prescriptions you should have functionality. Prescribing controlled substances is a different process. – resolved 03/22/18 2pm
Completed Physdoc notes are not crossing over to MPF. Items can be viewed under “Documents” in Clinician Hub. – issue resolved 3/19/18 at 9am
MPF (medical records) opens in separate window- This is the new default starting in Version 14. The pop-up window will close (even if minimized) when the focus is changed from the current patient. Previous issues of an orphaned window leading to hanged state should not occur. – Issue closed 03/20/18
Rounding report patients do not appear in sorted order by bed number. – Issue resolved 03/20/18
Paper order sheets and prescriptions will be used during downtime.
What are the new features in Paragon 14?
Updated Patient Card: Patient demographics are easier to see in the upper left hand corner.
Patient Profile (NEW): Report containing information such as advanced directives, allergies, demographics, family history, implants, home medications etc are now available in a single report. This report can be customized by the end user for their practice
New flowsheet search capabilities: Some flowsheets such as Lab can get very difficult yo navigate especially on long admissions. This new search function will allow the user to quickly scroll the needed row. In this example I searched for “chest”. I was taken to the Chest X-ray row with the specific row highlighted.
Prescription writer: Now allows for secure electronic submission of controlled substances
Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC) published a summary of existing recommendations and provided updated and new recommendations on the prevention of hepatitis B virus infection in the United States.
The new and updated recommendations are:
For all medically stable infants weighing ≥2,000 grams at birth and born to HBsAg-negative mothers, the first dose of hepatitis B vaccine should be administered within 24 hours of birth.
Permissive language for delaying the birth dose that was previously used in the recommendations has been removed.
Identification and Management of HBV-Infected Pregnant Women:
All hepatitis B surface antigen (HBsAg) positive pregnant women should be tested for hepatitis B DNA to guide the use of maternal antiviral therapy during pregnancy for the prevention of hepatitis B virus transmission.
A brief summary of the American Association for the Study of Liver Diseases (AASLD) guidelines for the use of maternal antiviral therapy to reduce perinatal Hepatitis B virus transmission is also included in the MMWR.
Management of Infants Born to Women Who Are HBsAg-Positive:
Infants born to women for whom HBsAg testing results during pregnancy are not available but have other evidence suggestive of maternal hepatitis B virus infection (presence of maternal HBV DNA, maternal HBeAg is positive, or the mother is known to be chronically infected with hepatitis B) should be managed as if born to an HBsAg-positive mother.
For infants who are transferred to a different facility after birth, staff at the transferring and receiving facilities should communicate with each other regarding the infant’s HepB vaccination and receipt of hepatitis B immune globulin (HBIG) to ensure prophylaxis is administered in a timely manner.
Management of Infants Born to Women with Unknown HBsAg Status
If it is not possible to determine the mother’s HBsAg status (e.g., where confidential safe surrender of infant occurs shortly after birth), the vaccine series should be completed according to the recommended schedule for infants born to HBsAg-positive mothers. Post-vaccination serologic testing and revaccination, if needed, is recommended for these infants.
For HBsAg-negative infants born to HBsAg-positive women who show no serologic immune response after receiving the initial HepB vaccine series, revaccinate the infant with a single challenge dose of HepB vaccine and repeat serologic testing (HBsAg and anti-HBs) one to two months later. If the infant remains HBsAg negative and has an anti-HBs of <10 mIU/mL following single dose revaccination, complete the second series on schedule with the two additional Hep B vaccine doses followed by post-vaccination serologic testing one to two months after the final dose.
Alternatively,basedonclinicalcircumstancesorparentpreference,HBsAg-negative infants born to HBsAg-positive women who show no serologic immune response after receiving the initial HepB vaccine series may instead be revaccinated with a second 3- dose series and retested one to two months after the final dose of vaccine.
As a reminder, post vaccination serologic testing of the infant should include HBsAg and anti-HBs. Anti-HBs testing should be performed using a method that allows detection of the protective concentration of anti-HBs (> 10mIU/mL).